Percutaneous vertebroplasty is a new treatment that entered the United States 5 years ago and is rapidly gaining popularity. The indications for treatment are back pain due to vertebral compression fractures associated with osteoporosis, benign or malignant vertebral tumors, etc. The procedure is guided by X-ray and a fine needle is inserted from the back into the vertebral body under local anesthesia to inject a bone cement called hydroxyapatite into the damaged or lax vertebral body, which has the effect of relieving pain and rebuilding the biomechanical strength of the bone. The rate of pain relief and functional recovery after treatment is 95%, and the rate of complications is only 1.5%. The patient can be out of bed after 4 hours of bed rest following percutaneous vertebroplasty, and most patients can be out of bed and walking the next day. Osteoporosis has become a common disease affecting middle-aged and elderly people, especially middle-aged and elderly women. Vertebral fractures caused by osteoporosis are often characterized by intractable back pain, which can not only lead to dysfunctional pain lasting for months, but can also cause fatal complications such as atelectasis, pneumonia, formation of deep vein thrombosis and pulmonary embolism. The application of percutaneous vertebroplasty is undoubtedly a boon for patients with compression fractures and vertebral metastases. Currently, Europe and the United States advocate percutaneous vertebroplasty as the first-line treatment option, and they believe that the advantages of using such treatment are: 1. Minimally invasive intervention under local anesthesia, with a short operative time and a clear pain relief effect. Percutaneous vertebroplasty is a minimally invasive intervention performed under local anesthesia, with a short operative time and clear pain relief. 2. 5. significantly reduced the time of bed rest and the need for companionship for patients with vertebral compression fractures.